Rituximab in stem cell transplantation for aggressive lymphoma

Curr Hematol Rep. 2004 Jul;3(4):227-9.

Authors

Steven M Horwitz¹, Sandra J Horning

Affiliation

¹ Oncology and Bone Marrow Transplantation, Stanford University, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

PMID: 15217551

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Hematopoietic Stem Cell Transplantation / methods*
Humans
Lymphoma / therapy*
Recurrence
Rituximab
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Rituximab